MedPath

Infections and Latent Autoimmune Diabetes in Adults

Completed
Conditions
Latent Autoimmune Diabetes in Adults
Type 2 Diabetes
Registration Number
NCT06167616
Lead Sponsor
Karolinska Institutet
Brief Summary

Infections are proposed risk factors for type 1 diabetes in children. The investigators will examine whether a diagnosis of infectious disease also confers an increased risk of latent autoimmune diabetes in adults.

Detailed Description

The investigators will use data from a population-based Swedish case-control study (ESTRID) with incident cases of LADA (n=597) and matched controls (n=2386). History of infectious disease are ascertained through national and regional patient registers. The investigators will estimate adjusted odds ratios (OR) with 95% CI for ≥1 respiratory (any/upper/lower), gastrointestinal, herpetic, other or any infectious disease episode, or separately, for 1 and ≥2 infectious disease episodes, within 0-1, 1-3, 3-5 and 5-10 years before LADA diagnosis/matching. Stratified analyses will be performed based on HLA risk genotypes and GADA levels.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5048
Inclusion Criteria
  • 35 years or older, residing in Scania or Uppsala county.
Exclusion Criteria
  • Less than 35 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
LADAUp to 10 years

≥35 years at diagnosis, GADA positivity (≥10 U/ml) and C-peptide concentrations of ≥0.2 nmol/L (IMMULITE) or ≥0.3 nmol/L (Cobas).

Secondary Outcome Measures
NameTimeMethod
Type 2 diabetesUp to 10 years

also ≥35, GADA negative and had C-peptide concentrations of \>0.60 (IMMULITE)/\>0.72 (Cobas) nmol/L.

Trial Locations

Locations (1)

Karolinska institute

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath